$75.34 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: $75.34 Billion

As of September 2023 GlaxoSmithKline has a market cap of $75.34 Billion. This makes GlaxoSmithKline the world's 178th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 2001 to 2023

End of year Market Cap

Year Market cap Change
2023$75.34 B4.74%
2022$71.93 B-34.07%
2021$109.10 B18.9%
2020$91.76 B-21.15%
2019$116.38 B23.9%
2018$93.93 B6.6%
2017$88.11 B-6.48%
2016$94.22 B-4.88%
2015$99.05 B-4.91%
2014$104.16 B-19.26%
2013$129.00 B21.97%
2012$105.76 B-8.18%
2011$115.19 B13.05%
2010$101.89 B-7.08%
2009$109.65 B13.45%
2008$96.66 B-30.35%
2007$138.78 B-8.6%
2006$151.83 B3.03%
2005$147.36 B4.74%
2004$140.69 B6.84%
2003$131.68 B16.71%
2002$112.83 B-26.62%
2001$153.76 B

End of Day market cap according to different sources

On Sep 29th, 2023 the market cap of GlaxoSmithKline was reported to be:

$75.34 Billion
by Yahoo Finance info icon info icon
$75.34 Billion
by CompaniesMarketCap info icon info icon
$74.22 Billion
by Iex Cloud info icon info icon
$74.22 Billion
by Nasdaq info icon info icon
$61.17 Billion
by Reuters info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$210.67 B 179.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$187.27 B 148.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$136.32 B 80.94%๐Ÿ‡ซ๐Ÿ‡ท France
$261.23 B 246.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$210.58 B 179.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
$11.43 B-84.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.90 B-97.48%๐Ÿ‡บ๐Ÿ‡ธ USA